Cidofovir

In the US, Cidofovir (cidofovir systemic) is a member of the drug class purine nucleosides and is used to treat CMV Retinitis and Smallpox Vaccine Reaction.

US matches:

• Cidofovir


• Cidofovir Intravenous

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J05AB12

CAS registry number (Chemical Abstracts Service)

0113852-37-2

Chemical Formula

C8-H14-N3-O6-P

Molecular Weight

279

Therapeutic Category

Antiviral agent

Chemical Name

Phosphonic acid, [[2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]-, (S)-

Foreign Names

• Cidofovirum (Latin)
• Cidofovir (German)
• Cidofovir (French)
• Cidofovir (Spanish)

Generic Names

• Cidofovir (OS: DCF)
• Cidofovir (OS: USAN, BAN)
• GS 0504 (IS: Gilead)
• GS 504 (IS: Gilead)
• HPMPC (IS: Gilead)

Brand Names

• Vistide
  Gilead, Austria; Gilead, Switzerland; Gilead, United Kingdom; Gilead, United States; Gilead Sciences, Sweden; Pfizer, Australia; Pfizer, Belgium; Pfizer, Germany; Pfizer, Spain; Pfizer, France; Pfizer, United Kingdom; Pfizer, Italy; Pfizer, Luxembourg; Pfizer, Portugal; Pfizer, Slovenia; Pharmacia, Czech Republic; Gilead, Netherlands

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.